Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

[11] van den Bergh JP(2010)American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis Endocr Pract 16 1-37

[12] de Vries F(2013)The Malaysian clinical guidance on the management of postmenopausal osteoporosis, 2012: a summary Int J Rheum Dis 16 30-40

[13] Rutten-van Molken MP(2011)A pragmatic view on pragmatic trials Dialogues Clin Neurosci 13 217-224

[14] Lips P(2008)FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385-397

[15] van Schoor NM(2010)Development and use of FRAX in osteoporosis Osteoporos Int 21 S407-S413

[16] Serrano AJ(2008)Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK Osteoporos Int 19 1395-1408

[17] Begona L(2005)Alcohol intake as a risk factor for fracture Osteoporos Int 16 737-742

[18] Anitua E(2005)Smoking and fracture risk: a meta-analysis Osteoporos Int 16 155-162

[19] Cobos R(2007)The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1033-1046

[20] Orive G(2005)Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study J Bone Miner Res 20 1349-1355

[11] van den Bergh JP(2010)American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis Endocr Pract 16 1-37

[12] de Vries F(2013)The Malaysian clinical guidance on the management of postmenopausal osteoporosis, 2012: a summary Int J Rheum Dis 16 30-40

[13] Rutten-van Molken MP(2011)A pragmatic view on pragmatic trials Dialogues Clin Neurosci 13 217-224

[14] Lips P(2008)FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385-397

[15] van Schoor NM(2010)Development and use of FRAX in osteoporosis Osteoporos Int 21 S407-S413

[16] Serrano AJ(2008)Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK Osteoporos Int 19 1395-1408

[17] Begona L(2005)Alcohol intake as a risk factor for fracture Osteoporos Int 16 737-742

[18] Anitua E(2005)Smoking and fracture risk: a meta-analysis Osteoporos Int 16 155-162

[19] Cobos R(2007)The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 1033-1046

[20] Orive G(2005)Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study J Bone Miner Res 20 1349-1355